These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32721962)

  • 1. Gut Microbiome and AKI: Roles of the Immune System and Short-Chain Fatty Acids.
    Gharaie S; Noel S; Rabb H
    Nephron; 2020; 144(12):662-664. PubMed ID: 32721962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
    Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
    Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiome and Acute Kidney Injury.
    Rabb H; Pluznick J; Noel S
    Nephron; 2018; 140(2):120-123. PubMed ID: 29961049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota control acute kidney injury severity by immune modulation.
    Yang J; Kim CJ; Go YS; Lee HY; Kim MG; Oh SW; Cho WY; Im SH; Jo SK
    Kidney Int; 2020 Oct; 98(4):932-946. PubMed ID: 32470493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the Gut Microbiota in Acute Kidney Injury.
    Kobayashi T; Iwata Y; Nakade Y; Wada T
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34067285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
    Huang W; Zhou L; Guo H; Xu Y; Xu Y
    Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota-derived D-serine protects against acute kidney injury.
    Nakade Y; Iwata Y; Furuichi K; Mita M; Hamase K; Konno R; Miyake T; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Sato K; Oshima M; Yoneda-Nakagawa S; Yamamura Y; Kaneko S; Miyamoto T; Katane M; Homma H; Morita H; Suda W; Hattori M; Wada T
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
    Chou YT; Kan WC; Shiao CC
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress in the role of gut microbiota in acute kidney injury.
    Chen T; Chang C; Hou B; Qiu L; Sun H; Zhu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):385-391. PubMed ID: 38970512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury.
    Zou YT; Zhou J; Zhu JH; Wu CY; Shen H; Zhang W; Zhou SS; Xu JD; Mao Q; Zhang YQ; Long F; Li SL
    Microbiol Spectr; 2022 Jun; 10(3):e0075922. PubMed ID: 35481834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.
    Pluznick JL
    Kidney Int; 2016 Dec; 90(6):1191-1198. PubMed ID: 27575555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
    Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
    Front Immunol; 2020; 11():1994. PubMed ID: 32973805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-derived short-chain fatty acids and kidney diseases.
    Li L; Ma L; Fu P
    Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Microbiota in Experimental Acute Kidney Injury.
    Shah N; Rabb H
    Nephron; 2023; 147(1):25-30. PubMed ID: 36195072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research Progress of Short Chain Fatty Acids in the Pathogenesis of Immune Thrombocytopenia--Review].
    Li XN; Qu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1296-1300. PubMed ID: 35981402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases.
    Ikeda T; Nishida A; Yamano M; Kimura I
    Pharmacol Ther; 2022 Nov; 239():108273. PubMed ID: 36057320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease.
    Aragonès G; González-García S; Aguilar C; Richart C; Auguet T
    Biomed Res Int; 2019; 2019():8507583. PubMed ID: 30719448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies.
    Lei J; Xie Y; Sheng J; Song J
    Ren Fail; 2022 Dec; 44(1):571-580. PubMed ID: 35350960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.